文献速递急性肾损伤慢性肾脏病

肠道来源氧化三甲胺通过CCR2介导巨噬细胞浸润促进急性肾损伤

Gut-derived trimethylamine N-oxide promotes CCR2-mediated macrophage infiltration in acute kidney injury.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

本研究在小鼠单侧肾缺血再灌注模型中,高胆碱饮食改变肠道菌群并升高TMAO水平,加重急性肾损伤及后续慢性肾脏病。单细胞分析发现TMAO促进单核细胞来源的CCR2+巨噬细胞浸润,CCR2缺失或拮抗剂RS-102895可减轻TMAO诱导的炎症和纤维化。

要点

  • 高胆碱饮食升高TMAO,加重缺血再灌注所致AKI及后续CKD。
  • TMAO促进单核细胞来源CCR2+巨噬细胞浸润,增强免疫细胞互作。
  • CCR2缺失或拮抗剂RS-102895可减轻TMAO诱导的肾脏炎症与纤维化。

核心结论

  • TMAO通过CCR2介导的巨噬细胞浸润促进缺血再灌注后急性和慢性期肾脏炎症与纤维化。
  • CCR2是缺血再灌注后急性期和慢性期的潜在治疗靶点。

研究设计与样本

  • 小鼠单侧肾缺血再灌注诱导AKI和CKD,高胆碱饮食观察TMAO对肾脏炎症、纤维化和巨噬细胞动态的影响。
  • 采用单细胞分析鉴定TMAO应答的巨噬细胞亚群。
  • 通过CCR2缺失和拮抗剂RS-102895干预验证机制。

主要发现

  • 高胆碱饮食改变肠道菌群并升高TMAO水平,加重缺血再灌注诱导的AKI和后续CKD。
  • 单细胞分析鉴定出单核细胞来源的CCR2+巨噬细胞亚群是对TMAO的关键应答者,加剧免疫细胞互作和肾损伤。
  • TMAO促进缺血再灌注后CCR2持续表达,增加巨噬细胞浸润。
  • CCR2缺失和拮抗剂RS-102895改善TMAO诱导的炎症和纤维化,减轻缺血再灌注所致肾损伤。

临床怎么用

  • 提示靶向TMAO-CCR2轴可能减轻缺血再灌注后AKI及后续CKD的炎症和纤维化。
  • CCR2拮抗剂RS-102895在动物模型中显示保护作用,但尚未提供临床推荐。

局限性

  • 研究为小鼠模型,结论外推到临床需进一步验证。
  • 原文未报告具体样本量、P值和效应量等数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammation is crucial in the development of acute kidney injury (AKI) and subsequent chronic kidney disease (CKD) following renal ischaemia-reperfusion (IR) injury. Gut microbiota metabolites trigger inflammation and affect IR-induced renal damage. Yet the driving factors and mechanisms are unclear. Trimethylamine N-oxide (TMAO), a gut-derived choline metabolite, is a strong pro-inflammatory factor that increases in patients with AKI and CKD. We hypothesized that TMAO can promote renal injury caused by IR. METHODS: Mice subjected to unilateral renal IR to induce AKI and CKD were fed a high-choline diet to observe the effects of TMAO on kidney inflammation, fibrosis and macrophage dynamics. RESULTS: A choline-rich diet altered the gut microbiota and elevated TMAO levels, exacerbating IR-induced AKI and subsequent CKD. Single-cell analysis identified a distinct subset of CCR2+ macrophages derived from monocytes as key responders to TMAO, intensifying immune cell interactions and worsening renal injury. TMAO promoted sustained CCR2 expression after IR, increasing macrophage infiltration. CCR2 deletion and antagonist RS-102895 improved TMAO-induced inflammation and fibrosis and alleviated renal injury induced by IR. CONCLUSIONS: Our study provides valuable insights into the link between TMAO and IR-induced renal inflammation and fibrosis, emphasizing the critical role of TMAO-mediated macrophage infiltration via CCR2 as a key therapeutic target in the acute and chronic phases after IR.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Ren Y, Wang Z, You L, et al. Gut-derived trimethylamine N-oxide promotes CCR2-mediated macrophage infiltration in acute kidney injury. Nephrol Dial Transplant. 2024. PMID: 38587855. doi:10.1093/ndt/gfae082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。